Vitrea develops dietary supplements that combine AREDS ingredients with a unique blend of carotenoids and antioxidants to combat Age-Related Macular Degeneration (AMD) by reducing oxidative stress and filtering harmful blue light. The company also offers digital tools for tracking eye health, empowering users to manage their vision proactively.
Funding
$120K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Age-related macular degeneration (AMD) is exacerbated by oxidative stress, nutritional deficiencies, and blue light exposure, leading to progressive vision loss. Traditional AREDS supplements may not provide a comprehensive blend of nutrients to address these multiple factors effectively.
Solution
Vitrea offers a range of dietary supplements formulated with AREDS ingredients, along with a blend of carotenoids, antioxidants, vital minerals, and Taurine, designed to combat AMD. These supplements aim to reduce oxidative stress, provide nutritional support, and filter harmful blue light, protecting the macula and preserving retinal health. Vitrea products are developed in collaboration with ophthalmologists and manufactured in a cGMP-certified and FDA-inspected laboratory.
Target Audience
The primary target audience includes individuals at risk of or diagnosed with age-related macular degeneration (AMD) seeking to proactively manage their eye health through nutritional supplementation.
Features
- AREDS-based formula enhanced with additional carotenoids and nutrients
- Antioxidant blend to counteract oxidative stress
- Vital minerals and Taurine for retinal support
- Carotenoids to filter harmful blue light
- Formulated by scientists in collaboration with board-certified ophthalmologists
- Manufactured in a cGMP-certified and FDA-inspected laboratory
- Access to exclusive resources, communities, and digital tools to track and maintain eye health (coming soon)